Picture of Mauna Kea Technologies SA logo

ALMKT — Mauna Kea Technologies SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Mauna Kea Receives 510(k) Clearance For Cellvizio Needle-Based AQ-Flex 19 Confocal Miniprobe

Feb 25 (Reuters) - MAUNA KEA TECHNOLOGIES SAS  MKEA.PA :
    * MAUNA KEA TECHNOLOGIES RECEIVES 510(K) CLEARANCE FOR THE CELLVIZIO® NEEDLE-BASED AQ-FLEX™
19
CONFOCAL MINIPROBE™ ENABLING PERIPHERAL LUNG NODULE TARGETING AND IMAGING
    * CELLVIZIO® AQ-FLEX PROBE IS CLEARED FOR USE WITH TRANSBRONCHIAL NEEDLES THROUGH EXISTING
BRONCHOSCOPES AND BRONCHOSCOPIC ACCESSORIES

Source text for Eikon:  ID:nBw1XpTZQa 
Further company coverage:  MKEA.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))

Recent news on Mauna Kea Technologies SA

See all news